Gestalt, a leading innovator in AI-powered digital pathology solutions, announced the completion of a $7.5 million Series A financing. The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and prominent angel investors from the Pacific Northwest.
Gestalt's PathFlow platform is used by leading healthcare, academic medical centers, and...
Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery
Precision for Medicine, a leading provider of next generation drug development research and services, and PathAI, a global leader in digital pathology, announced a strategic collaboration to partner on developing novel AI-based...
Clinical ink, a global leader in life science technology, announced the launch of TrialLens™, a fully integrated, AI-powered analytics dashboard that transforms how clinical trial eCOA data is visualized, queried, and interpreted. TrialLens delivers real-time, actionable insights into study operations, participant behavior, and digital biomarker metrics across decentralized and...
Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analytics, announced the successful closing of its seed funding round. It raised $7.2 million in new equity investments and converted $4.0 million into SAFEs, bringing the total funding raised since Araceli's spin-off from Phoseon Technology to $11.2 million....
Axtria InsightsMAx.ai Delivers an Enterprise-Grade Flexible Framework with 30+ Ready-to-Deploy Agents, Apps, and APIs
Axtria Inc., an AI-first data analytics innovator transforming life sciences, announced its next generation of Axtria InsightsMAx™. Powered by agentic AI, the new Axtria InsightsMAx.ai fundamentally reimagines how life sciences organizations harness artificial intelligence through a flexible...
Robust preclinical pipeline of non-hallucinogenic neuroplastogens designed as potential best-in-class treatments for neuropsychiatric and neurodegenerative diseases
Transneural Therapeutics, Inc. (Transneural), a preclinical-stage biotechnology company aiming to transform the treatment of neuropsychiatric and neurodegenerative diseases with novel neuroplastogens, announced its launch now. Transneural was founded to address the high unmet need...
Pradeepta Mishra’s deep technical expertise and leadership to help accelerate and scale Beghou’s expanding AI capabilities for life sciences companies
Beghou Consulting, a leading provider of data, analytics, and technology solutions to life sciences companies, announced that acclaimed artificial intelligence (AI) and machine learning leader Pradeepta Mishra has joined the company...
ViQi and Araceli Biosciences collaborated to integrate ViQi's AI-powered image analysis with Araceli's high-throughput imaging platform.
ViQi, Inc. and Araceli Biosciences announced a dynamic collaboration to leverage ViQi's revolutionary AI-driven image analysis technology with Araceli's unmatched imaging innovations of their cutting-edge Araceli Endeavor® Ultra High Throughput – High Content Imaging...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced the launch of the Tempus Advisory Board. The Tempus Advisory Board is a vital resource for the company in maintaining high standards and ensuring that the strategy and offerings continue...
Accelerates the NICU, enables newborn screening, and opens global market opportunities with on-site sequencing and decentralized interpretation
GeneDx, a leader in delivering improved health outcomes through genomic insights, announced its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation. The transaction enables GeneDx’s leadership in the next phase...
